M&G Investment Management LTD Mesoblast LTD Transaction History

M&G Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$2.94 - $4.18 $1.14 Million - $1.62 Million	-387,494 Reduced 40.01%	580,946 $1.91 Million
Q4 2022 Jan 27, 2023	SELL	$2.73 - $3.7 $959,758 - $1.3 Million	-351,560 Reduced 26.63%	968,440 $0
Q3 2021 Nov 09, 2021	BUY	$5.87 - $7.85 $3.09 Million - $4.14 Million	527,005 Added 66.46%	1,320,000 $7.93 Million
Q3 2020 Oct 26, 2020	SELL	$11.33 - $19.81 $6.78 Million - $11.9 Million	-598,480 Reduced 43.01%	792,995 $15.1 Million
Q2 2020 Jul 22, 2020	SELL	$4.2 - $15.45 $121,430 - $446,690	-28,912 Reduced 2.04%	1,391,475 $15.3 Million
Q1 2020 Apr 09, 2020	SELL	$3.38 - $10.63 $240,071 - $755,017	-71,027 Reduced 4.76%	1,420,387 $5.68 Million
Q4 2019 Jan 28, 2020	BUY	$5.74 - $7.42 $8.56 Million - $11.1 Million	1,491,414 New	1,491,414 $10.4 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.